Season Five Finale of "Married to Medicine" Will Make You Sick, In a Good Way!
When it comes to medical dramas, the ladies of "Married to Medicine," say skip the scripted dramas and go straight for their reality show. Season Five's finale airs on March 2nd and two of the stars join Cheddar for a sneak peak.
Toya Bush-Harris and Dr. Contessa Metcalfe say they have enjoyed being on the show immensely. For the pair, "Married to Medicine" has allowed them to better understand themselves and their relationships with their husbands.
Dr. Contessa says this show is all about them being honest and transparent with their lives. They are happy to put their issues and struggles out there because they believe other couples can learn from their real conversations and issues.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
The original Birkin bag created by Hermès for Jane Birkin in 1984 is up for auction in Paris. Sotheby’s expects the iconic bag to sell for hundreds of thousands of euros on Thursday.
Elon Musk’s artificial intelligence company is taking down antisemitic comments and other “inappropriate posts” made by its Grok chatbot, including some praising Adolf Hitler.
Joby CPO Eric Allison discusses the UAE’s historic EVTOL take off, marking Dubai as the launchpad for global air taxi adoption and Joby’s commercial readiness.